Saudi Arabia In-Vitro Diagnostics (IVD) Market Report by Application (Infectious Diseases, Diabetes, Blood Test, Nephrology, Cardiology, Oncology, Autoimmune Diseases, and Others), End-User (Hospital-Based Centres, Diagnostics Chains, Standalone Centres, and Others) 2024-2032

Saudi Arabia In-Vitro Diagnostics (IVD) Market Report by Application (Infectious Diseases, Diabetes, Blood Test, Nephrology, Cardiology, Oncology, Autoimmune Diseases, and Others), End-User (Hospital-Based Centres, Diagnostics Chains, Standalone Centres, and Others) 2024-2032

Report Format: PDF+Excel | Report ID: SR112025A1141

Market Overview:

The Saudi Arabia in-vitro diagnostics (IVD) market size reached US$ 728.2 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,049.1 Million by 2032, exhibiting a growth rate (CAGR) of 4% during 2024-2032.

Report Attribute 
Key Statistics
Base Year
2023
Forecast Years
2024-2032
Historical Years
2018-2023
Market Size in 2023
US$ 728.2 Million
Market Forecast in 2032
US$ 1,049.1 Million
Market Growth Rate 2024-2032 4%


Saudi Arabia currently represents the largest market for in-vitro diagnostics in the GCC region. In-vitro diagnostics, plays a significant role in in the Saudi Arabia healthcare system by providing accurate diagnosis and prognosis, which enables improved monitoring and treatment. Diagnostics represent only a small share of the total healthcare spending but are critical in medical decision making and reducing the burden of diseases and healthcare expenditures.

There has been a steady growth in the adoption of in-vitro diagnostics in Saudi Arabia. Increasing incidence rates of various infectious and chronic diseases represent some of the key drivers of the in-vitro diagnostics market in Saudi Arabia. The country’s population is currently around 33 Million and is growing annually at around 2%. According to Saudi Arabia’s General Authority of Statistics, elderly constituted 4.2% of the total Saudi population and are expected to increase further in the coming years. With an increasing elderly population, we expect the prevalence of a number of chronic diseases to increase significantly in the next few years. Moreover, catalyzed by rising physical inactivity and consumption of unhealthy diets, the prevalence of a number of lifestyle diseases have been increasing in the country. Saudi Arabia has one of the highest rates of obesity in the world. It is estimated that around 36% of the total population are obese. Additionally, the prevalence of hypertension was around 29% among males and around 24% among females. Saudi Arabia also has one of the highest prevalence of diabetes with around 19% of the adult population suffering from diabetes in the country. Some of the other factors catalyzing the growth of in-vitro diagnostics in Saudi Arabia include rising healthcare expenditures, improving healthcare infrastructure, initiatives by the government, rising awareness levels, etc.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the Saudi Arabia in-vitro diagnostics (IVD) market report, along with forecasts for the period 2024-2032. Our report has categorized the market based on application and end-user.

Breakup by Application:

  • Infectious Diseases
  • Diabetes
  • Blood Test
  • Nephrology
  • Cardiology
  • Oncology
  • Autoimmune Diseases
  • Others


On the basis of application, the market has been segmented into infectious diseases, diabetes, blood test, nephrology, cardiology, oncology, autoimmune diseases and others.

Breakup by End-User:

  • Hospital-Based Centres
  • Diagnostics Chains
  • Standalone Centres
  • Others


Based on end-user, the report finds that hospital-based centers currently represent the leading end-user of in-vitro diagnostics in Saudi Arabia.

Competitive Landscape:

The report also provides the competitive landscape and the profiles of key players operating in this market.

This report provides a deep insight into the Saudi Arabia in-vitro diagnostics (IVD) devices market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Saudi Arabia in-vitro diagnostics (IVD) market in any manner.

Report Coverage:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Million
Segment Coverage Application, End-User
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3699
Five User License: US$ 4699
Corporate License: US$ 5699
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Key Questions Answered in This Report

The Saudi Arabia In-Vitro Diagnostics (IVD) market was valued at US$ 728.2 Million in 2023.

We expect the Saudi Arabia In-Vitro Diagnostics (IVD) market to exhibit a CAGR of 4% during 2024-2032.

The growing adoption of in-vitro diagnostics to monitor the overall health of patients for curing, treating, and preventing chronic diseases is primarily driving the Saudi Arabia In-Vitro Diagnostics (IVD) market.

The sudden outbreak of the COVID-19 pandemic had led to the postponement of elective In-Vitro Diagnostics (IVD) procedures across the nation to reduce the risk of the coronavirus infection upon hospital visits and interaction with healthcare professionals or medical equipment.

Based on the application, the Saudi Arabia In-Vitro Diagnostics (IVD) market has been segregated into infectious diseases, diabetes, blood test, nephrology, cardiology, oncology, autoimmune diseases, and others. Among these, infectious diseases currently exhibit a clear dominance in the market.

Based on the end-user, the Saudi Arabia In-Vitro Diagnostics (IVD) market can be bifurcated into hospital-based centers, diagnostics chains, standalone centers, and others. Currently, hospital-based centers hold the largest market share.

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Saudi Arabia In-Vitro Diagnostics (IVD) Market Report by Application (Infectious Diseases, Diabetes, Blood Test, Nephrology, Cardiology, Oncology, Autoimmune Diseases, and Others), End-User (Hospital-Based Centres, Diagnostics Chains, Standalone Centres, and Others) 2024-2032
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials